In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing buprenorphine for pain, harm reduction for benzodiazepine use, and more!
Buprenorphine for the Management of Chronic Pain: National Guidance Document, Published by the VA Pharmacy Benefits Management Services and the National Formulary Committee in Collaboration with the VHA National Office of Pain Management, Opioid Safety and PDMP (PMOP), March 2024
Harm reduction approaches for the use of benzodiazepines: a scoping review, Published in Springer Nature Link, October 2025
Definitive urine drug test findings in patients prescribed opioids for pain from a large national database, Published in the Journal of Opioid Management, July-August 2022
Duration of Methadone and Buprenorphine-Naloxone Treatment, Published in JAMA Network Open, July 2025
Safe and Sufficient—Ibuprofen for Pediatric Musculoskeletal Injuries, Published in JAMA, January 2026